CTRI/2018/02/011941尚未招募4 期
An open label study of clinical efficacy and safety of sanjeevini thailam an ayurvedic local topical application for patients presenting with pain due to muscular aches, joint pain (arthritis), rheumatism, sprains, strains and backache
Isha Arogya Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1Patients attending the clinic in the age group of 12 years and above are included and both the sexes will be included
- •2Patients provisionally diagnosed with the symptom of pain and inflammation due to muscular aches, joint pain (arthritis), rheumatism, sprains, strains and backache are included the study with their consent
排除标准
- •1Those having pain due to fractures, ligament tears and major injuries due to accidents
- •2Patients with serious co-morbid illnesses such as known cardiac vascular disease, cancer induced pain, injuries due to fall or accidents, systemic illness like SLE,etc
- •3Patients below the age of 12 years and above 60 years
- •4Patients who are not willing to give informed written consent.
研究者
相似试验
尚未招募
3 期
A clinical trial to study the effects of combined therapy with Docetaxel and Doxorubicin in female patients with metastatic breast cancerCTRI/2014/01/004344CJSC RCI Syntez Russia40
已完成
4 期
To check the effect of oil on hair growth and dandruff.CTRI/2023/02/049425Buy happy Marketing LLP90
进行中（未招募）
1 期
Patisiran-LNP in Patients with hATTR Amyloidosis Disease Progression Post-Liver TransplantHereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis)MedDRA version: 20.0Level: PTClassification code 10007509Term: Cardiac amyloidosisSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10019889Term: Hereditary neuropathic amyloidosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-003519-24-DEAlnylam Pharmaceuticals, Inc.20
进行中（未招募）
1 期
Patisiran-LNP in Patients with hATTR Amyloidosis Disease Progression Post-Liver TransplantEUCTR2018-003519-24-ITALNYLAM PHARMACEUTICALS, INC.20
进行中（未招募）
1 期
Patisiran-LNP in Patients with hATTR Amyloidosis Disease Progression Post-Liver TransplantHereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis)MedDRA version: 20.0Level: PTClassification code 10007509Term: Cardiac amyloidosisSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10019889Term: Hereditary neuropathic amyloidosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-003519-24-FRAlnylam Pharmaceuticals, Inc.20